The MARS2 trial (Mesothelioma and Radical Surgery 2) was designed to evaluate the effectiveness of pleurectomy/decortication (P/D) surgery in patients with malignant pleural mesothelioma, a rare and aggressive cancer caused by asbestos exposure. The trial aimed to determine whether this surgery, which removes the lining of the lung and potentially other affected tissues, improves survival…